Goose hemorrhagic Polyomavirus VP1 antibody and antigen (recombinant protein)
Diagnostic anti-Goose hemorrhagic Polyomavirus VP1 antibodies pairs and antigen for animal health (animal Goose infectious disease Hemorrhagic Nephritis Enteritis of Geese) testing in ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA and POCT
Go to Avian/Bird/Poultry disease testing products collection >>
Product information
Catalog No. | Description | US $ Price (per mg) |
---|---|---|
GMP-VT-P210-Tg001-Ag01 | Recombinant Goose hemorrhagic Polyomavirus VP1 protein | $3090.00 |
GMP-VT-P210-Tg001-Ab01 | Anti-Goose hemorrhagic Polyomavirus VP1 mouse monoclonal antibody (mAb) | $3090.00 |
GMP-VT-P210-Tg001-Ab02 | Anti-Goose hemorrhagic Polyomavirus VP1 mouse monoclonal antibody (mAb) | $3090.00 |
GMP-VT-P210-Tg001-Ab03 | Anti-Goose hemorrhagic Polyomavirus VP1 human monoclonal antibody (mAb) | $3090.00 |
GMP-VT-P210-Tg001-Ab04 | Anti-Goose hemorrhagic Polyomavirus VP1 human monoclonal antibody (mAb) | $3090.00 |
Size: 1mg | 10mg | 100mg
Product Description
Cat No. | GMP-VT-P210-Tg001-Ag01 |
Product Name | Recombinant Goose hemorrhagic Polyomavirus VP1 protein |
Pathogen | Goose hemorrhagic Polyomavirus |
Expression platform | E.coli |
Isotypes | Recombinant Antigen |
Bioactivity validation | Anti-Goose hemorrhagic Polyomavirus VP1 antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in Goose hemorrhagic Polyomavirus level test of animal Goose infectious disease with Hemorrhagic Nephritis Enteritis of Geese. |
Tag | His | Product description | Recombinant Goose hemorrhagic Polyomavirus VP1 proteinwas expressed in E.coli - based prokaryotic cell expression system and is expressed with 6 HIS tag at the C-terminus. |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Paired antibody immunoassay validation in Sandwich ELISA, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays. |
Formulation | Lyophilized from sterile PBS, PH 7.4 |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Cat No. | GMP-VT-P210-Tg001-Ab01,GMP-VT-P210-Tg001-Ab02 |
Pathogen | Goose hemorrhagic Polyomavirus |
Product Name | Anti-Goose hemorrhagic Polyomavirus VP1 mouse monoclonal antibody (mAb) |
Expression platform | CHO |
Isotypes | Mouse IgG |
Bioactivity validation | Recombinant Goose hemorrhagic Polyomavirus VP1 antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-Goose hemorrhagic Polyomavirus antibodies in Goose hemorrhagic Polyomavirus level test of animal Goose infectious disease with Hemorrhagic Nephritis Enteritis of Geese. |
Product description | Anti-Goose hemorrhagic Polyomavirus VP1 mouse monoclonal antibody (mAb) is a mouse monoclonal antibody produced by CHO technology. The antibody is ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-Goose hemorrhagic Polyomavirus antibodies. |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Paired antibody immunoassay validation in Sandwich ELISA, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays. |
Formulation | Lyophilized from sterile PBS, PH 7.4 |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Cat No. | GMP-VT-P210-Tg001-Ab03,GMP-VT-P210-Tg001-Ab04 |
Pathogen | Goose hemorrhagic Polyomavirus |
Product Name | Anti-Goose hemorrhagic Polyomavirus VP1 human monoclonal antibody (mAb) |
Expression platform | CHO |
Isotypes | Human lgG1 |
Bioactivity validation | Recombinant Goose hemorrhagic Polyomavirus VP1 antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-Goose hemorrhagic Polyomavirus antibodies in Goose hemorrhagic Polyomavirus level test of animal Goose infectious disease with Hemorrhagic Nephritis Enteritis of Geese. |
Product description | Anti-Goose hemorrhagic Polyomavirus VP1 mouse monoclonal antibody (mAb) is a human monoclonal antibody produced by CHO. The antibody is ELISA validated as capture antibody and detection antibody pair. |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Paired antibody immunoassay validation in Sandwich ELISA, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays. |
Formulation | Lyophilized from sterile PBS, PH 7.4 |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
Validation Data
Click to get more Data / Case study about the product.
Pathogen Information
GHPV is a member of the family Parvoviridae, which consists of small non-enveloped viruses with a single-stranded DNA genome. Within the Parvoviridae, GHPV belongs to the genus Dependoparvovirus, which is characterized by the ability of its members to replicate in non-dividing cells.
The GHPV genome is about 5.2 kilobases in length and contains a single coding region that encodes for two main proteins: VP1 and VP2. VP1 is the major capsid protein that makes up the outer shell of the virus particle, while VP2 is a minor capsid protein that also plays a role in viral replication.
Transmission of GHPV typically occurs via the fecal-oral route, with the virus being shed in the feces of infected birds. Once ingested, the virus infects and replicates in the epithelial cells lining the gastrointestinal tract and then spreads systemically to other organs via the bloodstream.
Clinical signs of GHPV infection in geese can vary depending on the age and immune status of the bird. In young birds, the disease can be acute and severe, with symptoms such as fever, lethargy, anorexia, diarrhea, and bleeding from multiple sites, including the beak, eyes, and cloaca. Adult geese may develop a milder form of the disease that is characterized by reduced egg production and decreased fertility.
Diagnosis of GHPV infection can be challenging due to the varying severity and nonspecific nature of clinical signs. However, several diagnostic methods are available, including nucleic acid-based techniques such as polymerase chain reaction (PCR), reverse transcription PCR (RT-PCR), and quantitative PCR (qPCR). These methods target the VP1 gene sequence, which is highly conserved among GHPV strains.
Another method for detecting GHPV infection is enzyme-linked immunosorbent assay (ELISA), which detects the presence of antibodies against VP2 protein in infected individuals. ELISA can be useful for serological surveillance and for determining the prevalence of GHPV in a given population.
There is no specific treatment for GHPV infection, and management of affected flocks typically involves supportive care and prevention of secondary bacterial infections. Vaccines have been developed for GHPV, but their efficacy can vary depending on the strain of virus and the age of the bird.
In conclusion, Goose Hemorrhagic Polyomavirus (GHPV) is a DNA virus that primarily infects geese, causing hemorrhagic disease with varying clinical signs depending on the age and immune status of the bird. Diagnosis of GHPV infection can be challenging, but several diagnostic methods are available, including nucleic acid-based techniques and ELISA. Management of GHPV-infected flocks typically involves supportive care and prevention of secondary infections.
About GDU
GDU helps global diagnostic partners in high quality of raw material discovery, development, and application. GDU believes in Protein&antibody Innovation for more reliable diagnostic solutions.